diphtheria, tetanus, and acellular pertussis vaccine (DTaP)

BIOLOGICAL2 trials

Sponsors

Pfizer

Conditions

Healthy Subjects

Phase 3

Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants

CompletedNCT01200368

PfizerHealthy Subjects

Start: 2010-09-24End: 2011-11-30Updated: 2018-12-19

Phase 4

A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants.

CompletedNCT01250756

PfizerHealthy Subjects

Start: 2010-11-30End: 2012-03-31Updated: 2013-02-26